Matches in SemOpenAlex for { <https://semopenalex.org/work/W2888616905> ?p ?o ?g. }
- W2888616905 abstract "Glioma, which accounts for more than 30% of primary central nervous system tumours, is characterised by symptoms such as headaches, epilepsy, and blurred vision. Glioblastoma multiforme is the most aggressive, malignant, and lethal brain tumour in adults. Even with progressive combination treatment with surgery, radiotherapy, and chemotherapy, the prognosis for glioma patients is still extremely poor. Compared with the poor outcome and slowly developing technologies for surgery and radiotherapy, the application of targeted chemotherapy with a new mechanism has become a research focus in this field.Moreover, targeted therapy is promising for most solid tumours. The tumour-tropic ability of stem cells, including neural stem cells and mesenchymal stem cells, provides an alternative therapeutic approach. Thus, mesenchymal stem cell-based therapy is based on a tumour-selective capacity and has been thought to be an effective anti-tumour option over the past decades. An increasing number of basic studies on mesenchymal stem cell-based therapy for gliomas has yielded complex outcomes.In this review, we summarise the biological characteristics of human mesenchymal stem cells, and the current status and potential challenges of mesenchymal stem cell-based therapy in patients with malignant gliomas." @default.
- W2888616905 created "2018-08-31" @default.
- W2888616905 creator A5001143634 @default.
- W2888616905 creator A5002233490 @default.
- W2888616905 creator A5002450016 @default.
- W2888616905 creator A5012664679 @default.
- W2888616905 creator A5025851882 @default.
- W2888616905 creator A5035329527 @default.
- W2888616905 creator A5048567430 @default.
- W2888616905 creator A5057627125 @default.
- W2888616905 creator A5081263926 @default.
- W2888616905 creator A5090881781 @default.
- W2888616905 date "2018-08-24" @default.
- W2888616905 modified "2023-10-12" @default.
- W2888616905 title "Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas" @default.
- W2888616905 cites W1482127273 @default.
- W2888616905 cites W1551461802 @default.
- W2888616905 cites W1571768035 @default.
- W2888616905 cites W1948215485 @default.
- W2888616905 cites W1965970119 @default.
- W2888616905 cites W1970696168 @default.
- W2888616905 cites W1972455205 @default.
- W2888616905 cites W1980441719 @default.
- W2888616905 cites W1980776838 @default.
- W2888616905 cites W1981524443 @default.
- W2888616905 cites W1982402691 @default.
- W2888616905 cites W1986300999 @default.
- W2888616905 cites W1986457784 @default.
- W2888616905 cites W1987696021 @default.
- W2888616905 cites W1988149035 @default.
- W2888616905 cites W1991248271 @default.
- W2888616905 cites W1992270919 @default.
- W2888616905 cites W199447113 @default.
- W2888616905 cites W1996323262 @default.
- W2888616905 cites W1998269193 @default.
- W2888616905 cites W1999538067 @default.
- W2888616905 cites W2019713216 @default.
- W2888616905 cites W2022922272 @default.
- W2888616905 cites W2025371271 @default.
- W2888616905 cites W2035209595 @default.
- W2888616905 cites W2035773336 @default.
- W2888616905 cites W2044197183 @default.
- W2888616905 cites W2058280753 @default.
- W2888616905 cites W2059139137 @default.
- W2888616905 cites W2064213778 @default.
- W2888616905 cites W2064912301 @default.
- W2888616905 cites W2069006548 @default.
- W2888616905 cites W2072365921 @default.
- W2888616905 cites W2074819830 @default.
- W2888616905 cites W2077645726 @default.
- W2888616905 cites W2081134904 @default.
- W2888616905 cites W2083368916 @default.
- W2888616905 cites W2084653338 @default.
- W2888616905 cites W2085204161 @default.
- W2888616905 cites W2087165914 @default.
- W2888616905 cites W2090241102 @default.
- W2888616905 cites W2094155824 @default.
- W2888616905 cites W2096676113 @default.
- W2888616905 cites W2100764963 @default.
- W2888616905 cites W2103279664 @default.
- W2888616905 cites W2110341920 @default.
- W2888616905 cites W2113358240 @default.
- W2888616905 cites W2113435552 @default.
- W2888616905 cites W2115844597 @default.
- W2888616905 cites W2121699071 @default.
- W2888616905 cites W2125793635 @default.
- W2888616905 cites W2133473226 @default.
- W2888616905 cites W2134451319 @default.
- W2888616905 cites W2136499741 @default.
- W2888616905 cites W2137832464 @default.
- W2888616905 cites W2145099626 @default.
- W2888616905 cites W2147331510 @default.
- W2888616905 cites W2154526619 @default.
- W2888616905 cites W2156063893 @default.
- W2888616905 cites W2158115708 @default.
- W2888616905 cites W2159566378 @default.
- W2888616905 cites W2159999899 @default.
- W2888616905 cites W2160387923 @default.
- W2888616905 cites W2163803875 @default.
- W2888616905 cites W2166838688 @default.
- W2888616905 cites W2166869281 @default.
- W2888616905 cites W2170628618 @default.
- W2888616905 cites W2205001515 @default.
- W2888616905 cites W2262570740 @default.
- W2888616905 cites W2267136005 @default.
- W2888616905 cites W2290579097 @default.
- W2888616905 cites W2308374231 @default.
- W2888616905 cites W2325549616 @default.
- W2888616905 cites W2396620212 @default.
- W2888616905 cites W2406638233 @default.
- W2888616905 cites W2415378226 @default.
- W2888616905 cites W2536678251 @default.
- W2888616905 cites W2547358231 @default.
- W2888616905 cites W2561877185 @default.
- W2888616905 cites W2584286435 @default.
- W2888616905 cites W2590911431 @default.
- W2888616905 cites W2594021791 @default.
- W2888616905 cites W2611010678 @default.
- W2888616905 cites W2620951925 @default.
- W2888616905 cites W2751157361 @default.